Clinical Research
Therapeutic effect of stereotactic brain hematoma aspiration on hypertensive intracerebral hemorrhage in basal ganglia
Liu Qingbin, Zhou Zhihua, Liu Jinlian
Published 2017-07-15
Cite as IMHGN, 2017,27(14): 2218-2221. DOI: 10.3760/cma.j.issn.1007-1245.2017.14.020
Abstract
ObjectiveTo investigate the clinical efficacy of conservative treatment and stereotactic hematoma aspiration (SHA) in basal ganglia (BJR) hypertensive intracerebral hemorrhage (HICH) (15-30 ml small and medium hematoma).
MethodsSixty-six patients with hypertensive intracerebral hemorrhage were randomly divided into two groups according to the digital table method. 33 cases in the control group were treated with conventional conservative therapy, while 33 cases in the observation group were treated with stereotactic brain hematoma aspiration and conventional conservative therapy. The clinical efficacy of the two groups were compared.
ResultsThere was no dead case in the two groups. The complication rate was 9.09% (3/33) in the observation group, including 1 case of urinary tract infection, 1 case of pulmonary infection, 1 case of gastrointestinal bleeding; the complication rate was 23.24% (8/33) in the control group, including 2 cases of urinary tract infection, 4 cases of pulmonary infection, 2 cases of gastrointestinal bleeding; there was statistically significant difference in the complication rate between the two groups (χ2=2.7273, P<0.05). The time of hematoma absorption in the observation group was significantly shorter than that in the control group [(3.27±1.69)d vs.(11.46±3.87)d], with statistically significant difference (t=-11.141, P<0.05). The length of hospital stay in the observation group was significantly shorter than that in the control group [(16.58±4.02)d vs.(22.14±4.85)d], with statistically significant difference (t= -5.070, P<0.05). NIHSS scores at 2, 4, and 12 weeks after treatment were lower than that before treatment in the two groups (P<0.05), NIHSS scores at 2, 4 weeks after treatment in the observation group were lower than those in the control group (P<0.05), there was no statistically significant difference in the NIHSS score between the two groups at 12 weeks after treatment (P>0.05).
ConclusionStereotactic intracerebral hematoma aspiration can shorten the time of hematoma absorption, reduce the hospitalization time, reduce the incidence of complications, promote the early recovery of neurological function, and improve the quality of life effectively.
Key words:
Hypertensive intracerebral hemorrhage; Basal ganglia; Stereotactic brain hematoma aspiration; Conservative treatment
Contributor Information
Liu Qingbin
Department of Neurosurgery, Huidong Second People's Hospital, Huizhou 516351, China
Zhou Zhihua
Department of Radiology, Huidong Second People's Hospital, Huizhou 516351, China
Liu Jinlian
Department of Radiology, Huidong Second People's Hospital, Huizhou 516351, China